Effective dose from radiation exposure in medicine: Past, present, and future

Soil-to-banana transfer factor of radionuclides in Lampung, Indonesia

This study estimates the soil-to-banana transfer factor of radionuclides in southern of Lampung, Indonesia, a region influenced by a large coal-fired power plant (CFPP) and other heavy industrial activities. This region is renowned for its banana productions, exceeding 11,000 tons annually for both local consumption (notably greater Jakarta) and export. Coal combustion in CFPP concentrates natural radionuclides from a series of uranium and thorium within the resulting ash. Soil and banana samples from Srengsem, Mataram, and Rangai Tri Tunggal villages were analyzed for 226Ra, 232Th, and 40K using a calibrated P-type High-Purity Germanium (HPGe) detector. The study found average activity concentrations in soil were 26 ± 1 Bq kg-1 for 226Ra, 28 ± 1 Bq kg-1 for 232Th, and 368 ± 12 Bq kg-1 for 40K. In banana, 226Ra at 6 ± 1 Bq kg-1 and 40K at 288 ± 10 Bq kg-1 (40K) were detected, while 232Th below of limit detection. The transfer factors for 226Ra and 40K were counted at 0.3 ± 0.2 and 1.6 ± 1.3, respectively, showing medium to high uptake. The estimated effective dose was significantly below the BAPETEN limit of 1 mSv year-1, confirming that bananas cultivated in southern of Lampung area are safe for human consumption with minimal radiological impact. The findings underscore the critical insights into the safety of agricultural products produced in regions impacted by industrial activities and provides data for support the development of robust national food security management strategies.

A Comparative Study of 137Cs Dose Factors for Constant and Depth-dependent Soil Densities

ABSTRACT

Accurate assessment of external radiation dose rates from 137Cs is essential for evaluating radiological risk in environmental and occupational settings. This study refines dose conversion coefficient calculations by incorporating depth-dependent soil density and addressing limitations in conventional methods that assume constant soil density. We calculated dose conversion coefficients for 137Cs in soil, considering both exponential and Gaussian distributions of activity concentration. Using two models, one with constant density and another with variable density as a function of depth, we compared dose rates to quantify the effect of soil density variations. Results indicate that dose rates are consistently higher when depth-dependent density is applied. The effect is more pronounced when 137Cs activity is distributed over larger depths (i.e., greater relaxation lengths) or when broader Gaussian distributions are considered. This suggests that assuming constant soil density may lead to underestimations of dose rates, especially in heterogeneous or compacted soils. Our findings emphasize the importance of accounting for density variability in dose calculations to enhance radiological risk assessments for areas contaminated with 137Cs.Health Phys. 129(0):000-000; 2025.

Introduction of a hybrid approach based on statistical shape model and Adaptive Neural Fuzzy Inference System (ANFIS) to assess dosimetry uncertainty: A Monte Carlo study

The increasing use of ionizing radiation has raised concerns about adverse and long-term health risks for individuals. Therefore, to evaluate the range of risks and protection against ionizing radiation, it is necessary to assess the dosimetry calculation uncertainty of the absorbed dose of organs and tissues in the body. On the other hand, absorbed dose calculation with low computational load plays a noted role in dosimetry studies. Considering the Monte Carlo simulation's time-consuming and high computational cost, we present a novel model-based organ dosimetry for uncertainty evaluation. We attempt to model and estimate the organ-absorbed dose for lung organ size by combining computational phantoms and ANFIS. Two input variables were used, including variations in lung size and photon energy. The results showed that the proposed hybrid approach increased the speed of evaluation of the uncertainty of dosimetry calculations. The promising results of the hybrid approach demonstrate that it can be a suitable alternative to the time-consuming conventional methods of dosimetry calculations in dosimetry calculations, which will lead to the development of a rapid and reliable tool for organ dose estimation in dosimetry applications in the future.

Analysis of material composition and attenuation characteristics of anthropomorphic torso phantoms for dosimetry using dual energy CT technology

Anthropomorphic phantoms are often used to estimate organ absorbed doses. However, the material composition of these phantoms is not identical to that of the human body, which may cause errors in the measurement results. The purpose of this study was to analyze the material composition of several anthropomorphic torso phantoms using dual energy computed tomography (DECT), and to clarify the differences in attenuation characteristics among the phantoms. Anthropomorphic torso phantoms (ATOM, RANDO, and PBU-60) from different manufacturers were scanned with DECT. The target organs were lung, soft tissue, liver, bone, and bone surface, and a spectral Hounsfield unit curve (HU curve) was created from the relationship between energy and CT values. Ideal CT values were estimated from the mass attenuation coefficient and density proposed by the International Commission on Radiation Units and Measurements report 44 (ideal value) and compared with the values of each phantom. There were large differences in attenuation characteristics among the phantoms for soft tissue, liver, and bone. The respective ideal, ATOM, RANDO, and PBU-60 CT values of soft tissue were 59.82, 14.17, 34.22, and - 70.11 at 45 keV; and 53.13, 24.41, 3.97, and - 5.75 at 70 keV. The phantom closest to the ideal value may differ depending on the energy. Differences in HU curve and CT values indicate that some organs in the phantom have different material composition and attenuation characteristics to human tissues. When the phantoms available for dosimetry are limited, it is important to understand the attenuation characteristics of each phantom used.

A systematic review and meta-analysis of radiation exposure in spinal surgeries: Comparing C-Arm, CT navigation, and O-Arm techniques

INTRODUCTION

Advanced imaging techniques, such as C-arm fluoroscopy, O-arm, and CT navigation, are integral to achieving precision in orthopedic surgeries. However, these technologies also expose patients, surgeons, and operating room staff to varying levels of radiation. This systematic review and meta-analysis evaluate the radiation exposure (RE) associated with these imaging modalities and their impact on surgical outcomes.

METHODS

A comprehensive literature search was conducted following PRISMA guidelines, resulting in 2,725 identified articles. After removing duplicates and screening for eligibility, 24 studies were included in the analysis. Radiation exposure data, measured in milliSieverts (mSv) and milliGray (mGy), were standardized using conversion formulas. Quality assessments were performed using the Newcastle-Ottawa Scale (NOS) and ROB2 tools. Statistical analysis was conducted using random-effects models for comparing radiation exposure and fixed-effects models for secondary outcomes.

RESULTS

The meta-analysis included 11 studies: 8 studies comparing C-arm and CT navigation, and 3 studies comparing C-arm and O-arm technologies. The analysis revealed that CT navigation is associated with significantly higher RE compared to C-arm (Standardized Mean Difference (SMD): 4.73, 95% Confidence Interval (CI): 2.44 to 7.03; p < 0.0001). In contrast, there was no significant difference in RE between O-arm and C-arm (SMD: 1.34, 95% CI: -0.17 to 2.85; p = 0.082). Secondary analyses showed no significant differences in surgery duration or hospitalization length between CT navigation and C-arm techniques.

DISCUSSION

The results of this meta-analysis underscore the trade-offs between radiation exposure and surgical precision. While CT navigation significantly increases RE compared to C-arm fluoroscopy, it offers superior accuracy, particularly in critical precision surgeries such as spinal interventions. The lack of significant difference in RE between O-arm and C-arm technologies suggests that O-arm may provide a balanced approach, offering enhanced accuracy with radiation levels similar to C-arm. However, the significant heterogeneity among studies and inconsistent reporting of secondary outcomes indicate the need for further research. Future studies should focus on refining imaging techniques to optimize the balance between radiation safety and surgical accuracy.

CONCLUSION

C-arm imaging generally results in lower radiation exposure compared to CT navigation, making it preferable for standard procedures where extreme precision is not as critical. However, CT navigation's superior accuracy justifies its use in precision surgeries despite the higher radiation exposure. O-arm technology, with its comparable RE to C-arm and enhanced accuracy, represents a beneficial option where available. Ongoing research should aim to optimize imaging techniques, balancing the need for radiation safety with the demands for surgical precision.

Validation of SSDE calculation in a modern CT scanner and correlation with effective dose

This study aims to validate the Size Specific Dose Estimate (SSDE) provided by a modern Computed Tomography (CT) scanner and investigate its correlation with effective dose (E). SSDE is a size-specific dosimetric index addressing the limitations of the Computed Tomography Dose Index (CTDIvol). A set of 60 CT scans of anthropomorphic phantoms, including pediatric and obese models, were acquired and analyzed. SSDE values from the CT scanner were compared with those obtained through an independent Python-based calculation and Radimetrics, a dose monitor software. While the independent calculation and the one with Radimetrics were consistently in agreement, a systematic underestimation by the scanner up to 10% was seen, particularly in chest and abdominal exams. The underestimation, however, remained within the acceptable limits set by AAPM guidelines. Furthermore, a correlation between SSDE and effective dose was identified, suggesting SSDE's potential for more accurate, size-specific radiation dose and risk assessments. These findings highlight the importance of SSDE in enhancing patient-specific dose management, though further validation using patient data is needed to confirm its clinical applicability.

Developing a Mobile Application for Estimating Patient's Radiation Dose

In diagnostic radiology, entrance surface air kerma (ESAK) is one of the patient radiation dose quantities, and the effective dose is used as an estimator of possible risk for radiation exposure level. Calculation of the ESAK and effective dose requires both X-ray machine parameters and patient exposure parameters. Due to the high performance of smartphones and the increase in mobile applications, this study aimed to develop a mobile application to estimate the ESAK and effective dose in general radiography. The ESAK calculator was then developed using Android studio software, which is a standalone application operating on Android operating system version 5.0 or higher. X-ray machine parameters are initially required for calculating X-ray output. For the ESAK and effective dose calculation, exposure parameters for each examination are needed. The results showed that the average score of satisfaction was 4.64±0.13, which was very satisfactory. In conclusion, the ESAK calculator could be used for estimating ESAK and effective dose for individual radiographic examination.

Comparative effectiveness of digital variance and subtraction angiography in lower limb angiography: A Monte Carlo modelling approach

OBJECTIVE

By modelling patient exposures of interventional procedures, this study compares the reduction of radiation detriment between Digital Variance Angiography (DVA) and Digital Subtraction Angiography (DSA).

METHODS

The paper presents a retrospective risk assessment using an in-house developed tool on 107 patient exposures from a clinical trial of DVA used to diagnose peripheral arterial disease (PAD). DICOM exposure parameters were used to initiate the PENELOPE (PENetration and Energy LOss of Positrons and Electrons) Monte Carlo simulation, radiation quality and quantity, and irradiation geometry. The effective dose and the lifetime attributable risk (LAR) for cancer incidence and mortality are calculated based on the International Commission on Radiation Protection's (ICRP) 103 recommendations and the Committee on the Biological Effects of Ionising Radiations' latest (BEIR VII) report, respectively.

RESULTS

The study found that procedures conducted using DVA significantly reduce the radiation exposure of patients, compared to DSA. The collective effective dose for the DVA group was 58% lower than that for the DSA group. Correspondingly, the LAR of different organs showed a substantial decrease for cancer incidence (25-75%) and mortality (51-84%).

CONCLUSION

DVA demonstrates a considerable reduction in physical dosimetric quantities and consequently effective dose and cancer risk, suggesting its potential as a safer alternative to DSA in interventional radiology. The use of DVA supports the optimisation of patient radiation protection and aligns with the principles of ALARA (as low as reasonably achievable).

Evaluating the Utilization of the National Cancer Institute Computed Tomography Program for Calculating Size-specific Dose Estimate and Effective Dose in Computed Tomography in Thai Pediatric Patients

The objectives of this study were to assess the feasibility of utilizing computational calculations and the simulation of the National Cancer Institute computed tomography (NCICT) dosimetry system to obtain size-specific dose estimate (SSDE) and effective dose values resulting from the most common CT examinations in Thai pediatric patients and to evaluate age- and size-specific k conversion factor. For the calculation methods, SSDEs were calculated using the American Association of Physicists in Medicine Report No. 220 and 293 methodologies. The results revealed that SSDEs derived from CT scans of the body, obtained through the two different methods, varied by within 10%. The size of the patient and the scanning distance had an impact on the variability of E values derived from NCICT. Age- and size-specific k conversion factors may be used as a first line to estimate risk for the pediatric patients.

Recurrent medical imaging exposures for the care of patients: one way forward

Medical imaging is both valuable and essential in the care of patients. Much of this imaging depends on ionizing radiation with attendant responsibilities for judicious use when performing an examination. This responsibility applies in settings of both individual as well as multiple (recurrent) imaging with associated repeated radiation exposures. In addressing the roles and responsibilities of the medical communities in the paradigm of recurrent imaging, both the International Atomic Energy Agency (IAEA) and the American Association of Physicists in Medicine (AAPM) have issued position statements, each affirmed by other organizations. The apparent difference in focus and approach has resulted in a lack of clarity and continued debate. Aiming towards a coherent approach in dealing with radiation exposure in recurrent imaging, the IAEA convened a panel of experts, the purpose of which was to identify common ground and reconcile divergent perspectives. The effort has led to clarifying recommendations for radiation exposure aspects of recurrent imaging, including the relevance of patient agency and the provider-patient covenant in clinical decision-making. CLINICAL RELEVANCE STATEMENT: An increasing awareness, generating some lack of clarity and divergence in perspectives, with patients receiving relatively high radiation doses (e.g., ≥ 100 mSv) from recurrent imaging warrants a multi-stakeholder accord for the benefit of patients, providers, and the imaging community. KEY POINTS: • Recurrent medical imaging can result in an accumulation of exposures which exceeds 100 milli Sieverts. • Professional organizations have different perspectives on roles and responsibilities for recurrent imaging. • An expert panel reconciles differing perspectives for addressing radiation exposure from recurrent medical imaging.

Practical guidance on the assessment of radiation risks for diagnostic radiological examinations

Patient doses cannot be limited; instead, radiological examinations should be justified and optimised to ensure the necessary diagnostic or therapeutic effect with the lowest patient dose achievable. Assessment of the radiation risks from patient exposure is important part of the justification process. Hence, medical staff within the framework of their professional activities should possess necessary information on the data on radiation risk from different types of radiological procedures. An approach has been developed that allows considering age and gender dependences of the risk coefficients of radiogenic cancer and the age and gender distribution of patients for various radiological examinations to assess the individual radiation risk for patient and collective risk for population from medical exposure. The approach is based on a new expanded use of the effective dose concept proposed in ICRP Publication 147 and demonstrated using the medical exposure in the Russian Federation as the example. For 30 radiological examinations that compose about 80% of the collective dose from medical exposure of the public in the Russian Federation radiation risk was assessed based on calculated age and gender specific risk coefficients per unit effective dose. For the rest of the examinations a simplified approach was used to assess the risk, which was based on using an age and gender specific risk coefficient determined for one of 4 anatomical regions (head, neck, chest and abdomen) or for uniform irradiation of the whole body. The proposed approach allows significantly improving the assessment of the radiation risk while continuing to use the effective dose as a dosimetric quantity within the framework of the state program in the Russian Federation. As a result the collective risk from medical examinations in the Russian Federation in 2022 was lower by the factor of 3 compared to the previous assessment based on the effective dose with the nominal risk coefficient.

Estimation of organ and effective doses of CBCT scans of radiotherapy using size-specific field of view (FOV): a Monte Carlo study

The kV cone beam computed tomography (CBCT) is one of the most common imaging modalities used for image-guided radiation therapy (IGRT) procedures. Additional doses are delivered to patients, thus assessment and optimization of the imaging doses should be taken into consideration. This study aimed to investigate the influence of using fixed and patient-specific FOVs on the patient dose. Monte Carlo simulations were performed to simulate kV beams of the imaging system integrated into Truebeam linear accelerator using BEAMnrc code. Organ and size-specific effective doses resulting from chest and pelvis scanning protocols were estimated with DOSXYZnrc code using a phantom library developed by the National Cancer Institute (NCI) of the US. The library contains 193 (100 male and 93 female) mesh-type computational human adult phantoms, and it covers a large ratio of patient sizes with heights and weights ranging from 150 to 190 cm and 40 to 125 kg. The imaging doses were assessed using variable FOV of three sizes, small (S), medium (M), and large (L) for each scan region. The results show that the FOV and the patient size played a major role in the scan dose. The average percentage differences (PDs) for doses of organs that were fully inside the different FOVs were relatively low, all within 11% for both protocols. However, doses to organs that were scanned partially or near the FOVs were affected significantly. For the chest protocol, the inclusion of the thyroid in the scan field could give a dose of 1-7 mGy/100 mAs to the thyroid, compared to 0.4-1 mGy/100 mAs when it was excluded. Similarly, on average, testes doses could be 6 mGy/100 mAs for the male pelvis protocol compared to 3 mGy/100 mAs when it did not lie in the field irradiated. These dose differences resulted in an average increase of up to 27% in the size-specific effective dose of the protocols. Since changing the field size is possible for CBCT scans, the results suggest that patient-specific scanning protocols could be applied for each scan area in a manner similar to that used for CT scans. Adjustment of the FOV size should be subject to the clinical needs, and assist in improving the treatment accuracy. The patient's height and weight might be considered as the main factors upon which, the selection of the appropriate patient-specific protocol is based. This approach should optimize the imaging doses used for IGRT procedures by minimizing doses of a large ratio of patients.

An inventory of patient-image based risk/dose, image quality and body habitus/size metrics for adult abdomino-pelvic CT protocol optimisation

PURPOSE

Patient-specific protocol optimisation in abdomino-pelvic Computed Tomography (CT) requires measurement of body habitus/size (BH), sensitivity-specificity (surrogates image quality (IQ) metrics) and risk (surrogates often dose quantities) (RD). This work provides an updated inventory of metrics available for each of these three categories of optimisation variables derivable directly from patient measurements or images. We consider objective IQ metrics mostly in the spatial domain (i.e., those related directly to sharpness, contrast, noise quantity/texture and perceived detectability as these are used by radiologists to assess the acceptability or otherwise of patient images in practice).

MATERIALS AND METHODS

The search engine used was PubMed with the search period being 2010-2024. The key words used were: 'comput* tomography', 'CT', 'abdom*', 'dose', 'risk', 'SSDE', 'image quality', 'water equivalent diameter', 'size', 'body composition', 'habit*', 'BMI', 'obes*', 'overweight'. Since BH is critical for patient specific optimisation, articles correlating RD vs BH, and IQ vs BH were reviewed.

RESULTS

The inventory includes 11 BH, 12 IQ and 6 RD metrics. 25 RD vs BH correlation studies and 9 IQ vs BH correlation studies were identified. 7 articles in the latter group correlated metrics from all three categories concurrently.

CONCLUSIONS

Protocol optimisation should be fine-tuned to the level of the individual patient and particular clinical query. This would require a judicious choice of metrics from each of the three categories. It is suggested that, for increased utility in clinical practice, more future optimisation studies be clinical task based and involve the three categories of metrics concurrently.

What proportion of CT scan patients are alive or deceased after 10 years?

PURPOSE

When discussing radiation risks for patients who undergo many CT examinations, some question the risks, believing that most of these patients are already very sick and likely to die within a few years, thus negating worry about radiation risk. This study seeks to evaluate the validity of this notion.

METHODS

In this retrospective single large-hospital study, patients who received CT exams in 2013 were sorted into four cumulative effective dose (CED) groups: Group A (>0 to <10 mSv), Group B (10 to <50 mSv), Group C (50 to < 100 mSv), and Group D (≥100 mSv). The death rates of patients in each group were analyzed, up to December 2023.

RESULTS

36,545 patients underwent CT examinations in 2013 (mean age, 56 ± 20 years, 51.4 % men). Death rates for all dose groups peaked in the year of imaging or 1 year after. At one year after imaging, Group D had 6.7 times and Group C had 4.3 times the death rate of Group A. However, a significant portion of these patients are alive after 10 years, with 1324/2756 patients (48.0 %) in Group C and 282/769 patients (36.7 %) in Group D with the potential to face radiation effects.

CONCLUSIONS

While it is true that patients receiving relatively higher doses (≥50 mSv) are more likely to die within the first two years of receiving such doses, nearly one-third to half remain alive a decade after their CT scans, potentially facing the effects of radiation. This knowledge may help policymakers and practitioners.

The determination of coefficients for size specific effective dose for adult and pediatric patients undergoing routine computed tomography examinations

The effective dose resulting from computed tomography (CT) scans provides an assessment of the risk associated with stochastic effects but does not account for the patient's size. Advances in Monte Carlo simulations offer the potential to obtain organ dose data from phantoms of varying stature, enabling derivation of a size-specific effective doses (SEDs) representing doses to individual patients. This study aimed to compute size-specific k-conversion factors for SED in routine CT examinations for adult and pediatric patients of different sizes. Radiation interactions were simulated for adult and pediatric phantom models of various sizes using National Cancer Institute CT version 3.0.20211123. Subsequent calculations of SED were performed, and coefficients for SED were derived, considering the variations in body sizes. The results revealed a strong correlation between effective diameter and weight, observed with size-specific k-conversion factors for adult and pediatric phantoms, respectively. While size-specific k-conversion factors for CT brain remained constant in adults, values for pediatric cases varied. When using the tube current modulation (TCM) system, size-specific k-conversion factors increased in larger phantoms and decreased in smaller ones. The extent of this increase or decrease correlated with the set TCM strength. This study provides coefficients for estimating SEDs in routine CT exams. Software utilizing look-up tables of coefficients can be used to provide dose information for CT scanners at local hospitals, offering guidance to practitioners on doses to individual patients and improving radiation risk awareness in clinical practice.

Photon-Counting Computed Tomography: Experience in Musculoskeletal Imaging

Since the emergence of the first photon-counting computed tomography (PCCT) system in late 2021, its advantages and a wide range of applications in all fields of radiology have been demonstrated. Compared to standard energy-integrating detector-CT, PCCT allows for superior geometric dose efficiency in every examination. While this aspect by itself is groundbreaking, the advantages do not stop there. PCCT facilitates an unprecedented combination of ultra-high-resolution imaging without dose penalty or field-of-view restrictions, detector-based elimination of electronic noise, and ubiquitous multi-energy spectral information. Considering the high demands of orthopedic imaging for the visualization of minuscule details while simultaneously covering large portions of skeletal and soft tissue anatomy, no subspecialty may benefit more from this novel detector technology than musculoskeletal radiology. Deeply rooted in experimental and clinical research, this review article aims to provide an introduction to the cosmos of PCCT, explain its technical basics, and highlight the most promising applications for patient care, while also mentioning current limitations that need to be overcome.

Dose, dose, dose, but where is the patient dose?

The article reviews the historical developments in radiation dose metrices in medical imaging. It identifies the good, the bad, and the ugly aspects of current-day metrices. The actions on shifting focus from International Commission on Radiological Protection (ICRP) Reference-Man-based population-average phantoms to patient-specific computational phantoms have been proposed and discussed. Technological developments in recent years involving AI-based automatic organ segmentation and 'near real-time' Monte Carlo dose calculations suggest the feasibility and advantage of obtaining patient-specific organ doses. It appears that the time for ICRP and other international organizations to embrace 'patient-specific' dose quantity representing risk may have finally come. While the existing dose metrices meet specific demands, emphasis needs to be also placed on making radiation units understandable to the medical community.

Evaluating the Radioactive Waste Produced per Patient by Radiopharmaceutical Sources and Measuring the Radioactive Contamination of Surfaces and Staff at the Bushehr Nuclear Medicine Department

Background

Nuclear medicine is an integral and developing field in diagnosing and treating diseases. Monitoring individuals' protection and radiation contamination in the workplace is vital for preserving working environments.

Objective

This study aimed to monitor the nuclear medicine department's personnel, environment, and wastes to determine the level of occupational radiation and environmental pollution in Bushehr's nuclear medicine department.

Material and Methods

In this cross-sectional study, the initial activity of each radioisotope, radiopharmaceutical, and radioactive waste was measured using a "well counter" daily for three months. Three irradiators' absorbed doses were measured using a direct reading dosimeter. The contamination was determined using an indirect wipe test method on various surfaces. A Geiger Müller dosimeter was employed to examine personnel's hands, clothing, and footwear.

Results

The highest activity was observed in technetium waste (1118.31 mCi). Every irradiator received a lower absorption dose than the International Commission on Radiological Protection (ICRP) standard threshold. The majority of contamination was associated with the exercise test room (0.04 Bq/cm2) and its work surface (0.013 Bq/cm2), which were both below the threshold (0.5 Bq/cm2). Staff monitoring indicated that two nurses (10 and 11 individuals) had the highest contamination rate (23.7%).

Conclusion

Daily assessment of the type, activity, and method of radiopharmaceutical administration to the patient is advantageous for waste management. Surface contamination monitoring can significantly contribute to the estimation of the level of radiation pollution in the environment.

Cumulative radiation exposure from multimodality recurrent imaging of CT, fluoroscopically guided intervention, and nuclear medicine

OBJECTIVES

To assess cumulative effective dose (CED) over a 4-year period in patients undergoing multimodality recurrent imaging at a major hospital in the USA.

METHODS

CED from CT, fluoroscopically guided intervention (FGI), and nuclear medicine was analyzed in consecutive exams in a tertiary care center in 2018-2021. Patients with CED ≥ 100 mSv were classified by age and body habitus (underweight, healthy weight, overweight, obese), as per body mass index percentiles < 5th, 5th to < 85th, 85th to < 95th, and ≥ 95th (age 2-19 years), and its ranges < 18.5, 18.5-24.9, 25-29.9, and ≥ 30 (≥ 20 years), respectively.

RESULTS

Among a total of 205,425 patients, 5.7% received CED ≥ 100 mSv (mean 184 mSv, maximum 1165 mSv) and their ages were mostly 50-64 years (34.1%), followed by 65-74 years (29.8%), ≥ 75 years (19.5%), 20-49 years (16.3%), and ≤ 19 years (0.29%). Body habitus in decreasing occurrence was obese (38.6%), overweight (31.9%), healthy weight (27.5%), and underweight (2.1%). Classification by dose indicated 172 patients (≥ 500 mSv) and 3 (≥ 1000 mSv). In comparison, 5.3% of 189,030 CT patients, 1.6% of 18,963 FGI patients, and 0.19% of 41,401 nuclear-medicine patients received CED ≥ 100 mSv from a single modality.

CONCLUSIONS

The study of total dose from CT, FGI, and nuclear medicine of patients with CED ≥ 100 mSv indicates major (89%) contribution of CT to CED with 70% of cohort being obese and overweight, and 64% of cohort aged 50-74 years.

CLINICAL RELEVANCE STATEMENT

Multimodality recurrent exams are common and there is a lack of information on patient cumulative radiation exposure. This study attempts to address this lacuna and has the potential to motivate actions to improve the justification process for enhancing patient safety.

KEY POINTS

• In total, 5.7% of patients undergoing multimodality recurrent imaging (CT, fluoroscopically guided intervention, nuclear medicine) incurred a dose of ≥ 100 mSv. • Mean dose was 184 mSv, with 15 to 18 times contribution from CT than that from fluoroscopically guided intervention or nuclear medicine. • In total, 70% of those who received ≥ 100mSv were either overweight or obese.

Assessing Patient Radiation Exposure in Endoscopic Retrograde Cholangiopancreatography: A Multicenter Retrospective Analysis of Procedural Complexity and Clinical Factors

BACKGROUND AND AIMS

Endoscopic retrograde cholangiopancreatography (ERCP) procedures can result in significant patient radiation exposure. This retrospective multicenter study aimed to assess the influence of procedural complexity and other clinical factors on radiation exposure in ERCP.

METHODS

Data on kerma-area product (KAP), air-kerma at the reference point (Ka,r), fluoroscopy time, and the number of exposures, and relevant patient, procedure, and operator factors were collected from 2641 ERCP procedures performed at four university hospitals. The influence of procedural complexity, assessed using the American Society for Gastrointestinal Endoscopy (ASGE) and HOUSE complexity grading scales, on radiation exposure quantities was analyzed within each center. The procedures were categorized into two groups based on ERCP indications: primary sclerosing cholangitis (PSC) and other ERCPs.

RESULTS

Both the ASGE and HOUSE complexity grading scales had a significant impact on radiation exposure quantities. Remarkably, there was up to a 50-fold difference in dose quantities observed across the participating centers. For non-PSC ERCP procedures, the median KAP ranged from 0.9 to 64.4 Gy·cm2 among the centers. The individual endoscopist also had a substantial influence on radiation dose.

CONCLUSIONS

Procedural complexity grading in ERCP significantly affects radiation exposure. Higher procedural complexity is typically associated with increased patient radiation dose. The ASGE complexity grading scale demonstrated greater sensitivity to changes in radiation exposure compared to the HOUSE grading scale. Additionally, significant variations in dose indices, fluoroscopy times, and number of exposures were observed across the participating centers.

Characterizing imaging radiation risk in a population of 8918 patients with recurrent imaging for a better effective dose

An updated extension of effective dose was recently introduced, namely relative effective dose ( E r ), incorporating age and sex factors. In this study we extended E r application to a population of about 9000 patients who underwent multiple CT imaging exams, and we compared it with other commonly used radiation protection metrics in terms of their correlation with radiation risk. Using Monte Carlo methods, E r , dose-length-product based effective dose ( E DLP ), organ-dose based effective dose ( E OD ), and organ-dose based risk index ( RI ) were calculated for each patient. Each metric's dependency to RI was assessed in terms of its sensitivity and specificity. E r showed the best sensitivity, specificity, and agreement with RI (R2 = 0.97); while E DLP yielded the lowest specificity and, along with E OD , the lowest sensitivity. Compared to other metrics, E r provided a closer representation of patient and group risk also incorporating age and sex factors within the established framework of effective dose.

Evaluation of risks of cardiovascular disease from radiation exposure linked to computed tomography scans in the UK

Epidemiological studies of patient populations have shown that high doses of radiation increase risks of cardiovascular disease (CVD). Results from a recent meta-analysis of 93 epidemiological studies covering a wide range of doses provided evidence of a causal association between radiation exposure and CVD, and indicated excess relative risk per Gy for maximum dose below 500 mGy or delivered at low dose rates. These doses cover the range of organ doses expected from multiple diagnostic computed tomography (CT) scans. Dose-effect factors for the excess absolute risk of mortality from CVD following radiation exposure were derived from the meta-analysis. The present study uses these factors to estimate excess risks of mortality for various types of CVD, including cerebrovascular disease (CeVD), from CT scans of the body and head, assuming that the meta-analytic factors were accurate and represented a causal relationship. Estimates are based on cumulative doses to the heart and brain from CT scans performed on 105 574 patients on 12 CT scanners over a period of 5½ years. The results suggest that the excess number of deaths from CeVD could be 7 or 26 per 100 000 patients depending whether threshold brain doses of 200 mGy or 50 mGy, respectively are assumed. These results could have implications for head CT scans. However, the results rely on the validity of risk factors derived in the meta-analysis informing this assessment and which include significant uncertainties. Further incidence studies should provide better information on risk factors and dose thresholds, particularly for CeVD following head CT scans.

Optimal conversion coefficient from easily measurable dose to effective dose with consideration to radiation quality for posterior-anterior chest radiography

Effective dose is sometimes used to compare medical radiation exposure to patients and natural radiation for providing explanations about radiation exposure to patients, but its calculation is lengthy and requires dedicated measuring devices. The purpose of this study was to identify the most suitable conversion coefficient for conversion of easily measurable dose to effective dose in posterior-anterior chest radiography, and to evaluate its accuracy by direct measurement. We constructed an examination environment using Monte Carlo simulation, and evaluated the variation in conversion coefficients from incident air kerma (IAK), entrance-surface air kerma (ESAK), and air kerma-area product (KAP) to effective dose when the irradiation field size and radiation quality were changed. Effective doses were also measured directly using thermoluminescence dosimeters and compared with the effective dose obtained from conversion coefficients. The KAP conversion coefficient most effectively suppressed the effect of irradiation field size, and was then used to set conversion coefficients for various half-value layers. The optimal conversion coefficient was 0.00023 [mSv/(mGy·cm2)] at 120 kVp (half-value layer = 5.5 mmAl). Evaluation of the direct measurements obtained with various radiation qualities revealed that the accuracy of the conversion coefficient was maintained at ≤ 11%. The proposed conversion coefficient can be easily calculated even in facilities that do not have equipment for measuring effective dose, and might enable the use of effective dose for providing explanations about radiation exposure to patients.

Low-dose radiation induces unstable gene expression in developing human iPSC-derived retinal ganglion organoids

The effects of low-dose radiation on undifferentiated cells carry important implications. However, the effects on developing retinal cells remain unclear. Here, we analyzed the gene expression characteristics of neuronal organoids containing immature human retinal cells under low-dose radiation and predicted their changes. Developing retinal cells generated from human induced pluripotent stem cells (iPSCs) were irradiated with either 30 or 180 mGy on days 4-5 of development for 24 h. Genome-wide gene expression was observed until day 35. A knowledge-based pathway analysis algorithm revealed fluctuations in Rho signaling and many other pathways. After a month, the levels of an essential transcription factor of eye development, the proportion of paired box 6 (PAX6)-positive cells, and the proportion of retinal ganglion cell (RGC)-specific transcription factor POU class 4 homeobox 2 (POU4F2)-positive cells increased with 30 mGy of irradiation. In contrast, they decreased after 180 mGy of irradiation. Activation of the "development of neurons" pathway after 180 mGy indicated the dedifferentiation and development of other neural cells. Fluctuating effects after low-dose radiation exposure suggest that developing retinal cells employ hormesis and dedifferentiation mechanisms in response to stress.

A Tutorial on Diagnostic Benefit and Radiation Risk in Videofluoroscopic Swallowing Studies

The videofluoroscopic swallowing study (VFSS) is a key tool in assessing swallowing function. As with any diagnostic procedure, the probable benefits of the study must be weighed against possible risks. The probable benefit of VFSS is an accurate assessment of swallowing function, enabling patient management decisions potentially leading to improved patient health status and quality of life. A possible (though highly unlikely) risk in VFSS is carcinogenesis, arising from the use of ionizing radiation. Clinicians performing videofluoroscopic swallowing studies should be familiar with both sides of the risk benefit equation in order to determine whether the study is medically justified. The intent of this article is to provide the necessary background for conversations about benefit and risk in videofluoroscopic swallowing studies.

18F-alfatide II internal dosimetry using the ICRP 110 adult reference phantoms and the ICRP 103 tissue weighting factors

PURPOSE

¹⁸F-alfatide II is an arginine-glycine-aspartate (RGD) peptide-based PET tracer with promising imaging properties and pharmacokinetics. This study aims to calculate the absorbed and effective doses of ¹⁸F-alfatide II using the ICRP 110 adult reference phantoms and the ICRP 103 tissue weighting factors.

METHODS

The MIRD method was used in this study to calculate the absorbed dose of organs and tissues. The biokinetic data were taken from a previous study. These data are based on the whole-body PET imaging of mice.

RESULTS

The results show that the effective dose per unit activity administered of ¹⁸F-alfatide II is 1.33E-02 mSv/MBq. The urinary bladder wall receives the highest absorbed dose due to the administration of this radiopharmaceutical. Also, the effective dose of ¹⁸F-alfatide II is lower than that of ¹⁸F-FDG and some other RGD peptide-based tracers.

CONCLUSIONS

Dose calculation using ICRP 110 voxelized adult reference phantoms and ICRP 103 tissue weighting factors leads to more realistic and accurate results for 18F-alfatide II compared to the stylized phantoms. The calculated effective dose of ¹⁸F-alfatide II in the present study is lower than that of previously published data.

Computed tomography with adjusted dose for body mass index may be superior to whole-body radiography especially in elderly patients with multiple myeloma

BACKGROUND

Whole-body skeletal radiography has traditionally been used in the management of multiple myeloma for defining treatment strategies. For several reasons, radiography has been replaced by computed tomography (CT) covering the same regions.

PURPOSE

To evaluate the body mass index (BMI) adjusted effective radiation dose from two different methods of whole-body radiologic imaging for multiple myeloma assessment.

MATERIAL AND METHODS

The current investigation analyses the dose to patients resulting from the two methods, conventional radiography supplemented with tomosynthesis (203 examinations) and CT (264 examinations). All patients subject to myeloma staging for 4.5 years were included in the study. Exposure parameters were collected from the PACS and conversion factors were calculated using the software packages PCXMC and VirtualDose enabling the calculation of the effective dose to each patient based on BMI. The Mann-Whitney U test was used for comparisons between groups.

RESULTS

Patients were subject to a median effective dose of 2.5 mSv for conventional radiography and 5.1 mSv for CT, a statistically significant difference.

CONCLUSION

The effective dose for whole-body CT in assessing multiple myeloma is twice as high as for whole-body skeletal survey with modern digital radiography, but at a low level and considerably less than the levels quoted in the earlier studies of ∼30 mSv when the technique was first explored.

Typical effective dose values from diagnostic and interventional radiology

Effective dose (E) in medical procedures is of practical value for comparing doses from different types of procedures which is not possible with the different measurable dose quantities. In this survey we estimated and compared the values of E in 12 medical imaging procedures. The mean E for conventional X-ray in mSv were ranged between 0.01 for skull lateral to 0.5 for abdominal while the mean E for cardiac interventional radiology in mSv was up to 16 for percutaneous transluminal coronary angioplasty (PTCA). For dental radiology the mean E in μSv was 1.2 for intraoral and 10 for panoramic. In mammography the mean E was 0.5 mSv. Compared with the literature, chest postero-anterior (PA), lumbar spine AP, PTCA and mammography procedures had shown larger E values. The obtained results can help in justification of techniques.

Radiation dose evaluation to organs in neonatal patients by field size during potable X-ray examination in incubators: A Monte Carlo simulation study

BACKGROUND

Neonatal patients located in incubators are exposed to as many as 159 radiographs until discharge. To reduce the dose exposed to the patient, factors that may cause unnecessary exposure to the patient were judged. When conducting portable X-rays of neonatal patients located in an incubator, it is not easy to determine the exact field size because collimation light is exposed on the acrylic plate, an incubator canopy, and the resulting shadow is reflected on the patient's body.

OBJECTIVE

This study aims to measure the organ dose exposed to the patient according to the field size when a portable radiograph is given to a neonatal patient in a neonatal intensive care unit (NICU) incubator.

METHODS

To identify the absorbed organ dose depending on the radiation field size during portable X-ray examination of neonatal patient, a Monte Carlo N-Particle (MCNP) simulation, a SpeckCalc program, and a neonatal phantom from the ICRP 89 are applied for the calculation. According to the minimal field size (MinFS) standards of the European Commission (EC), the smaller field size is intended to measure tightly from the top of the lung apices to the bottom of the genitals; a larger field size is also calculated by adding 6 cm in width and length.

RESULTS

Compared to the hospital C condition from the previous study, the larger and smaller field sizes are decreased by an average of 45% and 67%, respectively. Study results also show a 42% reduction in smaller field size compared to the larger field size.

CONCLUSION

When taking chest and abdomen radiographic images of neonatal patients in incubators, appropriate field sizes are required to prevent inappropriate dose absorption for non-thoracic organs.

Identification and characterization of patients being exposed to computed-tomography associated radiation-doses above 100 mSv in a real-life setting

Rationale and objectives

Patients receiving high cumulative effective doses (CED) from recurrent computed tomography (CT) in a real-life setting are not well identified. Evaluation of causes and patient characteristics may help to define individuals potentially at risk of radiation-induced secondary malignancies.

Materials and methods

Patients who received a CED > 100 mSv from CT scans during October 2012 and April 2020 at a tertiary university center were identified with the help of a radiological radiation dose monitoring system. The primary disease and referral diagnosis, number of CT exams, time period, age, BMI and gender distribution of the 1000 patients with the highest CED were analysed.

Results

3431 patients had a CED of more than 100 mSv, which corresponded to 2.75% of all patients who received a CT exam. From the 1000 patients with the highest CED, mean number of CT exams per patient was 14.6, mean CED was 257 mSv (SD 98, range 177-1339). Mean age of patients was 63.9 years (SD 10.6), male to female ratio 3:2, and mean BMI 28.7 kg/m2 (SD 5.5). 728 (72.9%) patients had cancer. The leading primary diagnosis was liver cirrhosis in 197 patients and 103 patients had a liver transplantation. In patients with liver cirrhosis, 750 exams were indicated for the follow-up of the disease, 662 for the clarification of an acute clinical condition, and 202 for CT-guided stereotactic radiofrequency ablation.

Conclusion

Recurrent CT scans of patients with cancer, liver cirrhosis and liver transplantation may lead to critically high CED.

Variations in size-specific effective dose with patient stature and beam width for kV cone beam CT imaging in radiotherapy

The facilities now available on linear accelerators for external beam radiotherapy enable radiation fields to be conformed to the shapes of tumours with a high level of precision. However, in order for the treatment delivered to take advantage of this, the patient must be positioned on the couch with the same degree of accuracy. Kilovoltage cone beam computed tomography systems are now incorporated into radiotherapy linear accelerators to allow imaging to be performed at the time of treatment, and image-guided radiation therapy is now standard in most radiotherapy departments throughout the world. However, because doses from imaging are much lower than therapy doses, less effort has been put into optimising radiological protection of imaging protocols. Standard imaging protocols supplied by the equipment vendor are often used with little adaptation to the stature of individual patients, and exposure factors and field sizes are frequently larger than necessary. In this study, the impact of using standard protocols for imaging anatomical phantoms of varying size from a library of 193 adult phantoms has been evaluated. Monte Carlo simulations were used to calculate doses for organs and tissues for each phantom, and results combined in terms of size-specific effective dose (SED). Values of SED from pelvic scans ranged from 11 mSv to 22 mSv for male phantoms and 8 mSv to 18 mSv for female phantoms, and for chest scans from 3.8 mSv to 7.6 mSv for male phantoms and 4.6 mSv to 9.5 mSv for female phantoms. Analysis of the results showed that if the same exposure parameters and field sizes are used, a person who is 5 cm shorter will receive a size SED that is 3%-10% greater, while a person who is 10 kg lighter will receive a dose that is 10%-14% greater compared with the average size.

Comparison of patient effective doses from multiple CT examinations based on different calculation methods

The aim of this study is to compare effective dose (E) estimations based on different methods for patients with recurrent computed tomography (CT) examinations. Seventeen methods were used to determine the E of each phase as well as the total E of the CT examination. These included three groups of estimations: based on the use of published E, calculated from typical or patient-specific values of volume computed tomography dose index (CTDI_vol) and dose-length product (DLP) multiplied by conversion coefficients, and based on patient-specific calculations with use of software. The E from a single phase of the examination varied with a ratio from 1.3 to 6.8 for small size patients, from 1.2 to 6.5 for normal size patients, and from 1.7 up to 18.1 for large size patients, depending on the calculation method used. The cumulative effective dose (CED) ratio per patient for the different size groups varied as follows: from 1.4 to 2.5 (small), from 1.7 to 4.3 (normal), and from 2.2 up to 6.3 (large). The minimum CED across patients varied from 38 up to 200 mSv, while the variation of maximum CED was from 122 up to 538 mSv. Although E is recommended for population estimations, it is sometimes needed and used for individual patients in clinical practice. Its value is highly dependent on the method applied. Individual estimations of E can vary up to 18.1 times and CED estimations can differ up to 6 times. The related large uncertainties should always be taken into account.

Statement of the Italian Association of Medical Physics (AIFM) task group on radiation dose monitoring systems

The evaluation of radiation burden in vivo is crucial in modern radiology as stated also in the European Directive 2013/59/Euratom—Basic Safety Standard. Although radiation dose monitoring can impact the justification and optimization of radiological procedure, as well as effective patient communication, standardization of radiation monitoring software is far to be achieved. Toward this goal, the Italian Association of Medical Physics (AIFM) published a report describing the state of the art and standard guidelines in radiation dose monitoring system quality assurance. This article reports the AIFM statement about radiation dose monitoring systems (RDMSs) summarizing the different critical points of the systems related to Medical Physicist Expert (MPE) activities before, during, and after their clinical implementation. In particular, the article describes the general aspects of radiation dose data management, radiation dose monitoring systems, data integrity, and data responsibilities. Furthermore, the acceptance tests that need to be implemented and the most relevant dosimetric data for each radiological modalities are reported under the MPE responsibility.

Dose quantities for measurement and comparison of doses to individual patients in computed tomography (CT)

The dose quantities displayed routinely on CT scanners, the volume averaged CT dose index (CTDI_vol) and dose length product, provide measures of doses calculated for standard phantoms. The American Association of Medical Physics has published conversion factors for the adjustment of CTDI_volto take account of variations in patient size, the results being termed size-specific dose estimate (SSDE). However, CTDI_voland SSDE, while useful in comparing and optimising doses from a set procedure, do not provide risk-related information that takes account of the organs and tissues irradiated and associated cancer risks. A derivative of effective dose that takes account of differences in body and organ sizes and masses, referred to here as size-specific effective dose (SED), can provide such information. Data on organ doses from NCICT software that is based on Monte Carlo simulations of CT scans for 193 adult phantoms have been used to compute values of SED for CT examinations of the trunk and results compared with corresponding values of SSDE. Relationships within ±8% were observed between SED and SSDE for scans extending over similar regions for phantoms with a wide range of sizes. Coefficients have been derived from fits of the data to estimate SED values from SSDEs for different regions of the body for scans of standard lengths based on patient height. A method developed to take account of differences in scan length gave SED results within ±5% of values calculated using the NCI phantom library. This approach could potentially be used to estimate SED from SSDE values, allowing their display at the time a CT scan is performed.

The cumulative radiation dose paradigm in pediatric imaging

Medical imaging professionals have an accountability for both quality and safety in the care of patients that have unexpected or anticipated repeated imaging examinations that use ionizing radiation. One measure in the safety realm for repeated imaging is cumulative effective dose (CED). CED has been increasingly scrutinized in patient populations, including adults and children. Recognizing the challenges with effective dose, including the cumulative nature, effective dose is still the most prevalent exposure currency for recurrent imaging examinations. While the responsibility for dose monitoring incorporates an element of tracking an individual patient cumulative radiation record, a more complex aspect is what should be done with this information. This challenge also differs between the pediatric and adult population, including the fact that high cumulative doses (e.g.,>100 mSv) are reported to occur much less frequently in children than in the adult population. It is worthwhile, then, to review the general construct of CED, including the comparison between the relative percentage occurrence in adult and pediatric populations, the relevant pediatric medical settings in which high CED occurs, the advances in medical care that may affect CED determinations in the future, and offer proposals for the application of the CED paradigm, considering the unique aspects of pediatric care.

Radiation risk issues in recurrent imaging

Millions of patients benefit from medical imaging every single day. However, we have entered an unprecedented era in imaging practices wherein 1 out of 125 patients can be exposed to effective dose >50 mSv from a single CT exam and 3 out of 10,000 patients undergoing CT exams could potentially receive cumulative effective doses > 100 mSv in a single day. Recurrent imaging with CT, fluoroscopically guided interventions, and hybrid imaging modalities such as positron emission tomography/computed tomography (PET/CT) is more prevalent today than ever before. Presently, we do not know the cumulative doses that patients may be receiving across all imaging modalities combined. Furthermore, patients with diseases with longer life expectancies are being exposed to high doses of radiation enabling radiation effects to manifest over a longer time period. The emphasis in the past on improving justification of imaging and optimization of technique and practice has proved useful. While that must continue, the current situation requires imaging device manufacturers to urgently develop imaging technologies that are safer for patients as high doses have been observed in patients where imaging has been justified through clinical decision-support and optimized by keeping doses below the national benchmark doses. There is a need to have a critical look at the fundamental principles of radiation protection as cumulative doses are likely to increase in the coming years.

Why is radiological protection different in medicine? Sievert Memorial Lecture

There are many aspects of radiological protection in medicine that are different from other areas of activity using ionising radiation. In this paper, the author presents and justify some of these differences and highlight the reasons for and benefits of this consideration for the medical field. It is important to understand the differences as we are all likely to be patients at some point in our lives and be exposed to ionising radiation for imaging procedures several times and, in some cases, for therapeutic indications. The work done by the International Commission on Radiological Protection and other international organisations to produce and recommend a consistent system of radiological protection in medicine for the safe use of ionising radiation in medical practices must be highlighted. We should understand why we do not apply dose limits and dose constraints to patients, as well as why we have three levels of justification when considering the use of ionising radiation for patients. We highlight the relevance of personalised radiation protection in parallel to personalised medical practice, and the importance of an integrated approach for occupational and patient protection, especially for interventional procedures. We also cover the differences between patients and volunteers in biomedical research, the importance of radiation safety in quality assurance programmes (including the consideration of unintended and accidental exposures) for some clinical practices, and the relevance of education and training in radiological protection for medical and health professionals and information on radiation risks for patients. Finally, the ethical issues with regard to the safe use of ionising radiation in medicine and the impact of new technology will be addressed.

Experimental examination of radiation doses from cardiac and liver CT perfusion in a phantom study as a function of organ, age and sex

Cardiac and liver computed tomography (CT) perfusion has not been routinely implemented in the clinic and requires high radiation doses. The purpose of this study is to examine the radiation exposure and technical settings for cardiac and liver CT perfusion scans at different CT scanners. Two cardiac and three liver CT perfusion protocols were examined with the N1 LUNGMAN phantom at three multi-slice CT scanners: a single-source (I) and second- (II) and third-generation (III) dual-source CT scanners. Radiation doses were reported for the CT dose index (CTDI_vol) and dose-length product (DLP) and a standardised DLP (DLP_10cm) for cardiac and liver perfusion. The effective dose (ED_10cm) for a standardised scan length of 10 cm was estimated using conversion factors based on the International Commission on Radiological Protection (ICRP) 110 phantoms and tissue-weighting factors from ICRP 103. The proposed total lifetime attributable risk of developing cancer was determined as a function of organ, age and sex for adults. Radiation exposure for CTDI_vol, DLP/DLP_{10 cm}and ED_{10 cm}during CT perfusion was distributed as follows: for cardiac perfusion (II) 144 mGy, 1036 mGy·cm/1440 mGy·cm and 39 mSv, and (III) 28 mGy, 295 mGy·cm/279 mGy·cm and 8 mSv; for liver perfusion (I) 225 mGy, 3360 mGy·cm/2249 mGy·cm and 54 mSv, (II) 94 mGy, 1451 mGy·cm/937 mGy·cm and 22 mSv, and (III) 74 mGy, 1096 mGy·cm/739 mGy·cm and 18 mSv. The third-generation dual-source CT scanner applied the lowest doses. Proposed total lifetime attributable risk increased with decreasing age. Even though CT perfusion is a high-dose examination, we observed that new-generation CT scanners could achieve lower doses. There is a strong impact of organ, age and sex on lifetime attributable risk. Further investigations of the feasibility of these perfusion scans are required for clinical implementation.

Assessment of patients' cumulative doses in one year and collective dose to population through CT examinations

PURPOSE

To estimate percentage of patients undergoing multiple CT exams leading to cumulative effective dose (CED) of more than 25, 50, 75 and 100 mSv in one year and assess per capita and the collective effective dose.

METHODS

Data from a regional hospital network was collected retrospectively using radiation dose monitoring system at 6 facilities with 8 CT scanners. The data was analyzed to find number of patients in different dose groups, their age, gender, number of CT exams and exams needed to reach 100 mSv based on age groups.

RESULTS

In one year 43,010 patients underwent 75,252 CT examinations. The number of exams per 1000 population was 153. Further 27% of the patients were younger than 55- years and 15.9% of them were younger than 45-year-old. A total of 0.67% of patients received a CED > 100 mSv; 3.5% had CED > 50 mSv, 11.9% with CED > 25 mSv and the maximum CED was 529 mSv. The minimum time to reach 100 mSv was a single CT exam. Seven patients received > 100 mSv in a single CT exam. 0.36% of patients had 10 or more CT exams in one year and 3.8% had 5 or more CT exams. The mean CED was 12.3 mSv, the average individual effective dose was 1.1 mSv and the collective effective dose was 521.3 person-Sv.

CONCLUSIONS

The alarming high CED received by large number of patients and with high collective dose to population requires urgent actions by all stake holders in the best interest of patient radiation safety.

Dosimetric quantities and effective dose in medical imaging: a summary for medical doctors

This review presents basic information on the dosimetric quantities used in medical imaging for reporting patient doses and establishing diagnostic reference levels. The proper use of the radiation protection quantity "effective dose" to compare doses delivered by different radiological procedures and different imaging modalities with its uncertainties and limitations, is summarised. The estimates of population doses required by the European Directive on Basic Safety Standards is commented on. Referrers and radiologists should be familiar with the dose quantities to inform patients about radiation risks and benefits. The application of effective dose on the cumulative doses from recurrent imaging procedures is also discussed. Patient summary: Basic information on the measurement units (dosimetric quantities) used in medical imaging for reporting radiation doses should be understandable to patients. The Working Group on "Dosimetry for imaging in clinical practice" recommended that a brief explanation on the used dosimetric quantities and units included in the examination imaging report, should be available for patients. The use of the quantity "effective dose" to compare doses to which patients are exposed to from different radiological procedures and its uncertainties and limitations, should also be explained in plain language. This is also relevant for the dialog on to the cumulative doses from recurrent imaging procedures. The paper summarises these concepts, including the need to estimate the population doses required by the European Directive on Basic Safety Standards. Referrers and radiologists should be familiar with the dose quantities to inform patients about radiation risks and benefits.

Radiation protection perspective to recurrent medical imaging: what is known and what more is needed?

This review summarises the current knowledge about recurrent radiological imaging and associated cumulative doses to patients. The recent conservative estimates are for around 0.9 million patients globally who cumulate radiation doses above 100 mSv, where evidence exists for cancer risk elevation. Around one in five is estimated to be under the age of 50. Recurrent imaging is used for managing various health conditions and chronic diseases such as malignancies, trauma, end-stage kidney disease, cardiovascular diseases, Crohn's disease, urolithiasis, cystic pulmonary disease. More studies are needed from different parts of the world to understand the magnitude and appropriateness. The analysis identified areas of future work to improve radiation protection of individuals who are submitted to frequent imaging. These include access to dose saving imaging technologies; improved imaging strategies and appropriateness process; specific optimisation tailored to the clinical condition and patient habitus; wider utilisation of the automatic exposure monitoring systems with an integrated option for individual exposure tracking in standardised patient-specific risk metrics; improved training and communication. The integration of the clinical and exposure history data will support improved knowledge about radiation risks from low doses and individual radiosensitivity. The radiation protection framework will need to respond to the challenge of recurrent imaging and high individual doses. The radiation protection perspective complements the clinical perspective, and the risk to benefit analysis must account holistically for all incidental and long-term benefits and risks for patients, their clinical history and specific needs. This is a step toward the patient-centric health care.

Patient Size-Dependent Dosimetry Methodology Applied to 18F-FDG Using New ICRP Mesh Phantoms

Despite the known influence of anatomic variability on internal dosimetry, dosimetry for 18F-FDG and other diagnostic radiopharmaceuticals is routinely derived using reference phantoms, which embody population-averaged morphometry for a given age and sex. Moreover, phantom format affects dosimetry estimates to varying extent. Here, we applied newly developed mesh format reference phantoms and a patient-dependent phantom library to assess the impact of height, weight, and body contour variation on dosimetry of 18F-FDG. We compared the mesh reference phantom dosimetry estimates with corresponding estimates from common software to identify differences related to phantom format or software implementation. Our study serves as an example of how more precise patient size-dependent dosimetry methodology could be performed. Methods: Absorbed dose coefficients were computed for the adult mesh reference phantoms and derivative patient-dependent phantom series by Monte Carlo simulation using the PHITS radiation transport code within PARaDIM software. The dose coefficients were compared with reference absorbed dose coefficients obtained from ICRP Publication 128, or generated using software including OLINDA 2.1, OLINDA 1.1, and IDAC-dose 2.1. Results: Differences in dosimetry arising from anatomical variations were shown to be significant, with detriment-weighted dose coefficients for the percentile-specific phantoms varying by up to ±40% relative to the corresponding reference phantom effective dose coefficients, irrespective of phantom format. Similar variations were seen in the individual organ absorbed dose coefficients for the percentile-specific phantoms relative to the reference phantoms. The effective dose coefficient for the mesh reference adult was 0.017 mSv/MBq, which was 5% higher than estimated by a corresponding voxel phantom, and 10% lower than estimated by the stylized phantom format. Conclusion: We observed notable variability in 18F-FDG dosimetry across morphometrically different patients, supporting the use of patient-dependent phantoms for more accurate dosimetric estimations relative to standard reference dosimetry. These data may help in optimizing imaging protocols and research studies, in particular when longer-lived isotopes are employed.

Multicentric study of patients receiving 50 or 100 mSv in a single day through CT imaging-frequency determination and imaging protocols involved

OBJECTIVES

To assess the magnitude and characterization of CT imaging protocols of patients receiving 50 or 100 mSv in a single day.

METHODS

In this multicentric retrospective study covering up to 279 hospitals from January 2015 to December 2019, the effective dose (E) as estimated by dose management system from dose length product of patients was filtered and grouped into per-day dose bands (≤ 20, > 20-50, > 50-70, > 70-100, > 100-200, > 200 mSv). Information on patient's age and imaging protocol was noted. The data were analyzed to determine the frequency of occurrence in each dose band. Top 20 CT imaging protocols that led to patients with a dose of ≥ 50 mSv in a single acquisition were identified and their relative frequency was estimated.

RESULTS

A total of approx. 4.3 million (4,283,738) CT exams were performed in approx. 3.9 million (3,880,524) patient-days indicating 9.41% had more than one CT exam in a single day. There were 31,058 (0.8%) patient-days with ≥ 50 mSv and 1191 (0.03%) with ≥ 100 mSv. Nearly 1/3^rd patient-days reaching ≥ 50 mSv were of patients aged 50 years or younger. The top 20 CT imaging protocols that led to ≥ 50 mSv in a single day belonged to the body region (chest or abdomen and pelvis) and nearly one-third were angiographic studies.

CONCLUSIONS

In the first study of its kind, we report that patients with 50 mSv+ in a single day or a single exam are not rare. The information on imaging protocols leading to such doses and their frequency has been provided to help develop dose management strategies.

KEY POINTS

• Our study of 4,283,738 CT exams performed in 3,880,524 patient-days indicates 0.8% with 50 mSv+ and 0.03% with 100 mSv+ in a single day. • A total of 9.41% underwent more than one CT exam in a single day; nearly 1/3^rd of those with 50 mSv+ were ≤ 50 years of age. • Identified top 20 CT imaging protocols that led to 50 mSv+ doses in a single exam. All belong to chest or abdomen and pelvis and nearly 1/3^rd were angiographic studies.

Probability of receiving a high cumulative radiation dose and primary clinical indication of CT examinations: a 5-year observational cohort study

OBJECTIVE

High radiation exposure is a concern because of the association with cancer. The objective was to determine the probability of receiving a high radiation dose from CT (from one or more examinations within a 5-year period) and to assess the clinical context by evaluating clinical indications in the high-dose patient group.

DESIGN

Observational cohort study. Effective radiation dose received from one or more CT examinations within a predefined 5-year calendar period was assessed for each patient.

SETTING

Hospital setting.

PARTICIPANTS

All patients undergoing a diagnostic CT examination between July 2013 and July 2018 at the Maastricht University Medical Center.

PRIMARY AND SECONDARY OUTCOME MEASURES

The primary outcome was the probability of receiving a high effective dose, defined as ≥100 mSv, from one or more CT examinations within 5 years as derived from a time-to-event analysis. Secondary outcomes were the clinical indication for the initial scan of patients receiving a high effective dose.

RESULTS

100 672 CT examinations were performed among 49 978 patients including 482 (1%) who received a high radiation dose. The estimated probability of a high effective dose from a single examination is low (0.002% (95% CI 0.00% to 0.01%)). The 4.5-year probability of receiving a high cumulative effective dose was 1.9% (95% CI 1.6% to 2.2%) for women and 1.5% (95% CI 1.3% to 1.7%) for men. The probability was highest in age categories between 51 and 74 years. A total of 2711 (5.5%) of patients underwent more than six CT examinations, and the probability of receiving a high effective dose was 16%. Among patients who received a high effective dose, most indications (80%) were oncology related.

CONCLUSIONS

The probability of receiving a high radiation dose from CT examinations is small but not negligible. In the majority (80%) of high effective dose receiving patients, the indication for the initial CT scan was oncology related.